Attached files
| file | filename |
|---|---|
| EX-99.2 - EXHIBIT 99.2 - PRO FORMA FINANCIALS - AYTU BIOPHARMA, INC | ex_252279.htm |
| EX-99.1 - EXHIBIT 99.1 - NEOS HISTORICAL FINANCIALS - AYTU BIOPHARMA, INC | ex_252278.htm |
| 8-K/A - FORM 8-K/A - AYTU BIOPHARMA, INC | aytu20210520_8ka.htm |
Ex. 23.1
Consent of Independent Auditor
We consent to the incorporation by reference in the Registration Statements on Forms S-3 (No. 333-239010), S-4 (No. 333-239011) and S-8 (No. 333-205462 and No. 333-236598) of Aytu BioPharma, Inc. of our report dated March 22, 2021, relating to the consolidated financial statements of Neos Therapeutics, Inc. and Subsidiaries as of December 31, 2020 and 2019 and each of the three years in the period ended December 31, 2020, appearing in this Current Report on Form 8-K/A.
/s/ RSM US LLP
Dallas, Texas
May 21, 2021